ABSTRACT These studies were undertaken to assess the estrogenic and antiestrogenic effects of dietary genistein. To determine estrogenic effects, genistein was mixed into a modified AIN-76 or AIN-93G semipurified diet at 0 (negative control), 150, 375 or 750 mg/g and 17, b-estradiol at 1.0 mg/g and fed to ovariectomized 70-d-old Sprague-Dawley rats. Estrogenic potency was determined by analyzing uterine weight, mammary gland development, plasma prolactin and expression of uterine c-fos. Dietary genistein (375 and 750 mg/g) increased uterine wet and dry weights (P õ 0.05). Mammary gland regression following ovariectomy was significantly inhibited by dietary genistein at 750 mg/g (P õ 0.05). Plasma prolactin was significantly greater in ovariectomized rats fed genistein (750 mg/g) compared with comparable rats not receiving genistein. The relative binding affinity of genistein to the estrogen receptor (ER) was Ç0.01 that of estradiol. Genistein (750 mg/g) induced the uterine expression of c-fos. To evaluate potential antiestrogenic effects, genistein and estradiol were mixed into the modified AIN diets at the doses noted above and fed to ovariectomized rats. Dietary genistein (375 or 750 mg/g) did not inhibit the effects of estradiol on uterine weight, mammary gland development or plasma prolactin. Serum concentration of total genistein (conjugated plus free) in rats fed 750 mg/g was 2.2 mmol/L and free genistein was 0.4 mmol/L. Administration of dietary genistein at 750 mg/g can exert estrogenic effects in the uterus, mammary gland and hypothalamic/pituitary axis. Dietary genistein (750 mg/g) did not antagonize the action of estradiol in estradiolsupplemented ovariectomized rats or in intact rats.
subterranean clover (Bradbury and White 1951) . Genistein is Phytoestrogens include the isoflavones, lignans and other an isoflavone (4,5,7-trihydroxyisoflavone), which has estrononsteroidal chemicals found in plants and plant products.
genic activity (Folman and Pope 1966) , present in various These compounds can bind to the estrogen receptor and are plants including soybeans (Naim et al. 1974) . Since the initial thought to exert their estrogenic effects through mechanisms discovery of its estrogenic activity, there have been a number similar to those of estradiol.
of studies in which the effects of soy and genistein on the The consumption of certain plants and plant products can uterus of mice and rats were evaluated (Carter et al. 1953 ): result in impaired reproductive function in livestock. Over five all of these studies demonstrated estrogenic effects except the decades ago, clover disease, a syndrome with effects ranging work of Farmakalidis and Murphy (1984) . In their study, the from temporary to permanent infertility, was described in potent estrogen agonist diethylstilbestrol also did not promote sheep foraging upon subterranean clover in western Australia uterotrophic effects in this strain of mouse (CD-1). (Bennets et al. 1946) . Additional studies have documented
The estrogenic effects of genistein in the uterus are well impaired reproductive function in a number of species (redocumented. However, few experiments have been conducted viewed in Price and Fenwick 1985) including desert quail to assess estrogenic effects in other tissues, and to our knowlfeeding upon desert brush (Leopold et al. 1976) . Furthermore, edge, none have examined the effects of dietary genistein on a decrease in reproductive performance was observed in female the mammary gland or the hypothalamic/pituitary axis. These rats fed either a soy-based diet or a diet supplemented with studies were undertaken to provide additional insight into the genistin at 2 g/kg diet , and in male mice actions of dietary genistein by analyzing its effects on the fed genistin at 36 mg/(mouserd) (Matrone et al. 1955 ). All uterus, pituitary gland and mammary gland. In addition, the of these effects were attributed to the phytoestrogen content plasma concentration of genistein responsible for these estroof the diets.
genic effects was also determined. It was later discovered that genistein was responsible for the impaired reproductive performance seen in sheep ingesting MATERIALS AND METHODS 1 The costs of publication of this article were defrayed in part by the payment Chemicals. Genistein was synthesized by the demethylation of of page charges. This article must therefore be hereby marked ''advertisement'' biochanin A or from organic precursors as described by Chang et al. in accordance with 18 USC section 1734 solely to indicate this fact. 2 To whom correspondence should be addressed.
magnetic resonance (NMR) 3 and purity assessed at ú98%.
3 H-17, determined for each uterus by incubating approximately one-half of the uterus at 100ЊC for 16 h. b-Estradiol (3.59 TBq/mmol) and 32 P-deoxycytidine 5-triphosphate, tetra(triethylammonium) salt (111 TBq/mmol) were purchased from Analysis of mammary glands. Rats were weighed, anesthetized by CO 2 exposure and then killed by cervical dislocation. Mammary Dupont New England Nuclear (Boston, MA). All other chemicals, unless otherwise specified, were purchased from Sigma, St. Louis, MO.
glands were prepared according to the procedure of Banerjee et al. (1976) . The inguinal mammary gland was excised, fixed in a 3:1 Animals. All rats were maintained according to guidelines in the Guide for the Care and Use of Laboratory Animals (NRC 1985) . Intact (v/v) solution of ethanol:acetic acid for 2 h, transferred to 70% ethanol for 3 d with ethanol changed each day, rinsed in water and and ovariectomized 60-d-old Sprague-Dawley rats (Harlan, Indianapolis, IN) weighing from 200 to 225 g were used in Experiments 1 stained in alum-carmine for 16 h. The glands were then rinsed in water, placed in 70, 95 and 100% ethanol for 30 min each, transferred and 2. In Experiment 3, intact 30-d-old rats weighing from 80 to 90 g were used. Upon receipt, rats were weighed and sorted to equalize to toluene for 24 h for clarification and then stored in absolute methyl salicylate. Lobulo-alveolar and ductal structure (extent of side animal weights within each treatment group. Unless otherwise noted, rats were acclimated to the animal care facility and diet for 7 d prior branching) were assessed using a dissecting microscope and assigned values from 0 to 4, with the higher number representing maximal to initiating the studies. Rats were maintained in the animal care facility with temperature 22 { 2ЊC, relative humidity (40-70%), development. Analyses were performed twice on each gland with the identity of the glands unknown to the analyst. and a 12-h light:dark cycle. Rats were housed in polycarbonate cages (3 rats/cage) with aspen woodchip bedding and were allowed unNorthern blot analysis of c-fos. Total RNA was isolated by the procedure of Chirgwin et al. (1979) as modified by Helferich et al. restricted access to food and water.
Diets. Animals were fed the American Institute of Nutrition-(1990) . Uteri from four rats in each group (randomly selected from the following groups: ovariectomized control, 1 mg/g estradiol and 93G (AIN-93G) or modified AIN-76 diets prepared in our facilities. For the AIN-76 diet cornstarch was substituted for sucrose to lower 750 mg/g genistein) were removed from liquid nitrogen, placed in 4.0 mL of 4.0 mol/L guaninidium thiocyanate (GITC) and homogenized the sucrose concentration from 50 g/100 g to 10 g/100 g of the diet. Semipurified diets are required because the potential presence of on ice with a polytron (Brinkman Instruments, Westbury, NY) . NLauryl sarcosyl was added (100 mL 10% solution per milliliter GITC), genistein and other phytoestrogens in the soy portion of commercial nonpurified diets could confound the experimental results. Genistein the mixture vortexed and cellular debris removed by centrifugation at 12,000 1 g (g max) for 10 min. The supernatant was removed and and 17,b-estradiol were mixed into the AIN-76 or AIN-93G diets at the concentrations specified in Experiments 1, 2 and 3. layered over 1.0 mL of 5.7 mol/L CsCl followed by centrifugation at 110,000 1 g (g max) for 16 h. The pellet was resuspended in 7 mol/ Experiment 1: estrogenic effects of dietary genistein and estradiol. Forty-two rats were ovariectomized at 56 d of age and dietary L guanidine-HCl, 20 mmol/L sodium acetate, 1 mmol/L dithiothreitol, 10 mmol/L iodoacetic acid and 1 mmol/L Na 2 EDTA and transtreatments were begun at 70 d of age. The ovariectomized rats (6/ treatment) were given free access to food and water for a period of ferred to a 1.5-mL microfuge tube. RNA was precipitated with 2 volumes absolute ethanol and 0.1 volume 300 mmol/L sodium acetate 5 d. Dietary treatments consisted of genistein at 150, 375 and 750 mg/g or estradiol at 0.5, 1.0 and 1.5 mg/g. Eight intact and six ovariecat 020ЊC. RNA precipitates were washed once with 3 mol/L sodium acetate and 10 mmol/L iodoacetate, pH 5.0 at 4ЊC, then with 66% tomized 70-d-old rats were fed a modified AIN-76 diet and served as positive and negative controls, respectively. Estrogenic activity was ethanol and 33 mmol/L sodium acetate, pH 5.0, and then with absolute ethanol at 020ЊC. Ethanol was removed and the RNA pellet assessed by uterine wet and dry weights.
Experiment 2: anti-estrogenic activity of dietary genistein. dissolved in Tris-EDTA (pH 8.0) and spectrophotometrically quantified at 260/280 nm. Ten micrograms of RNA was loaded onto a 1.2% Forty-six rats were ovariectomized at 56 d of age and fed the modified AIN-76 diet until 70 d of age at which time dietary treatments were agarose formaldehyde denaturing gel and electrophoresed for 8 h at 35 V. The RNA was transferred to membrane (Hybond-N, Amerbegan. Rats, six per group, were given free access to food and water for a period of 21 d. Dietary treatments included estradiol at 1.0 mg/ sham Life Sciences, Cleveland, OH), and the membrane exposed to UV light at 120 kJ/cm 2 for 2 min. Rat c-fos cDNA, 2100 bp, was g, genistein at 750 mg/g, genistein at 150, 375 and 750 mg/g plus estradiol at 1.0 mg/g and an untreated control group. Ten ovariectokindly provided by Tom Curran (Roche Institute of Molecular Biology, Nutley, NJ) and probes made by random priming (Boeringer mized rats were killed at the start of the experiment to obtain baseline values for uterine weight and mammary gland development.
Mannheim, Indianapolis, IN) with incorporation of 32 P-deoxycytidine 5-triphosphate. The membrane was blocked by prehybridizing Estrogenic activity was assessed by comparing uterine weight, mammary gland development, plasma prolactin and uterine expression of with herring sperm DNA at 42ЊC for 4 h followed by hybridization for 12 h and subsequent washing at 65ЊC with 2X saline sodium an estrogen responsive gene, c-fos, to those of ovariectomized, untreated controls. Antiestrogenic activity of genistein was assessed by citrate buffer (SSC) / 0.1% sodium dodecyl sulfate (SDS) for 30 min each, then 0.3X SSC / 0.1% SDS for 25 min. The hybridized comparing the uterine weight, mammary development and plasma prolactin of rats consuming diets with varying combinations of genmembrane was exposed to Kodak X-OMAT film at 070ЊC for 3 d and then developed. istein and estradiol to the rats fed the diet containing 1.0 mg/g estradiol.
Plasma prolactin analysis. Plasma prolactin concentration was determined in the laboratory of Keith Lookingland at Michigan State Experiment 3: effects of dietary genistein on the development of the mammary gland and uterus of intact rats. Thirty-four 30-d-old University utilizing a double antibody RIA employing reagents and procedures of the National Institute for Diabetes and Digestive and rats were fed the AIN-93G diet for 1 d and treatments began on the second day. Rats, eight per group, were given free access to food and Kidney Disease (NIDDK) assay kit (generously supplied by A. F. Parlow and S. Ratti, National Hormone and Pituitary Program, Rockwater for a period of 14 d. Dietary treatments consisted of genistein at 375 and 750 mg/g. Eight rats fed the AIN-93G diet without genville, MD). NIDDK rat PRL RP-3 was used as the standard. Using a 100-mL aliquot of plasma, the lower limit of sensitivity was 10.0 mg/ istein served as positive controls. Ten rats were killed at the start of the experiment to establish base-line values for uterine weight and L. Samples from each rat were assayed in duplicate at two different dilutions in a single radioimmunoassay. mammary gland development.
Analysis of uteri. Rats were weighed, anesthetized by CO 2 expoCompetitive binding analysis. Competitive binding analysis with sure and then killed by cervical dislocation. Uteri were excised, 3 H-estradiol was performed using uterine cytosol prepared from untrimmed of fat and connective tissue, weighed and immediately placed treated rats consuming a nonpurified diet (22/5 Rodent Diet (w) in liquid nitrogen for later RNA analysis. Wet uterine weight was 8640, Harlan-Teklad, Madison, WI). Rat uteri were placed in icedetermined in all experiments. In Experiment 1, dry weight was also cold TEDG (10.0 mmol/L tris-HCl pH 7.4, 1.5 mmol/L EDTA pH 7.4, 1.0 mmol/L dithiothreitol added fresh, and 10% glycerol) and homogenized with a polytron (Brinkman Instruments). The homogenate was centrifuged at 800 1 g for 10 min, and the resulting superna-dry-ice bath and stored at 070ЊC. Binding assays were composed of 200 mL uterine cytosol (1.0 mg total protein), TEDG, and genistein or estradiol in ethanol vehicle bringing the total volume to 500 mL. Assays containing 5.0 nmol/L 3 H-estradiol and 0-20 nmol/L 17,bestradiol or 0-50 mmol/L genistein were incubated at 4ЊC for 3 h. After incubation, the contents were removed and placed in a microfuge tube containing the pellet from 250 mL of dextran-coated charcoal (DCC) solution (5% Norit A, 0.5% dextran T-70 in TEDG) to remove the unbound 3 H-estradiol. The microfuge tube was vortexed to disperse the DCC pellet and incubated for 3 min at 23ЊC followed by centrifugation at 13,000 1 g to pellet the DCC. Two 200-mL aliquots of the supernatant were collected and counted on a scintillation counter (Beckman Instruments Model LS100, Fullerton, CA). The counts were averaged, divided by the total counts and expressed as a percentage of the total radioactivity.
Serum genistein analysis. Rats were anesthetized with diethyl ether, and blood (Ç6 mL/rat) was collected from the tail artery. Blood was placed at 4ЊC for 16 h to allow clotting. The blood was then centrifuged at 350 1 g for 10 min and the serum removed and stored at 070ЊC. For genistein analysis, 50 mL of serum, from each compared with intact rats at the same age used in Experiment Statistical analyses. All statistical tests were performed using a 1 (Table 1) (Table 2 ).
prior to ANOVA. Data are means and standard errors before transIn Experiment 3, the effect of genistein on the development formation. When a significant (P õ 0.05) treatment effect was of the uterus of intact immature rats was evaluated. Ten rats detected, treatment means were compared using the least significant difference method (Steel and Torrie 1980) . Mammary gland data were analyzed by the Kruskal-Wallis nonparametric test (Shavelson   TABLE 1 1988). When a significant (P õ 0.05) treatment effect was detected, treatment rank means were compared using the least significant Effect of dietary genistein and estradiol on uterine weight in difference method (Steel and Torrie 1980 Values are means { SEM. The experimental groups included an ovariectomized control, baseline, genistein (Gen) 750 mg/g, estradiol FIGURE 2 Effect of dietary genistein and estradiol on the uterine (E 2 ) 1 mg/g, E 2 1 mg/g / 150 mg/g Gen, E 2 1 mg/g / 375 mg/g Gen, expression of c-fos in ovariectomized mature rats. Total RNA was preand E 2 1 mg/g / 750 mg/g Gen. Values in a column with different pared from four rats randomly selected from each of the following superscripts are significantly different (P õ 0.05). ANOVA was pertreatment groups: lanes 1-4 control, 5-8 750 mg/g genistein and 9-formed on log-transformed uterine weight data followed by multiple 12 1.0 mg/g 17, b-estradiol. Ten micrograms of total RNA was electromeans comparison using the least significant difference method.
phoresed on a 1.2% denaturing agarose gel, transferred to nylon and 2 Baseline rats were killed at the beginning of dietary treatment.
hybridized with random primed rat c-fos DNA probe labeled with 32 P. 3 Plasma prolactin was not determined in the baseline and E 2 / Gen
The film was exposed for 3 d. 150 treated rats. Uterine weights in these groups did not differ. 4 Control rats were ovariectomized, nontreated.
criteria: 1) lobulo-alveolar structure and 2) ductal structure were killed at the beginning of the study to obtain base-line including side branching and infiltration of ducts into the fat data for uterine weights. Baseline uterine weights were similar pad of the mammary gland. Dietary treatment of ovariectoto the uterine weights of the ovariectomized rats observed in mized rats for 21 d with 750 mg/g genistein prevented mamExperiments 1 and 2, thereby confirming the immaturity of mary gland regression, seen primarily in lobulo-alveolar structhe rats in this study. Dietary genistein administered at either ture, relative to that of the ovariectomized, untreated control 375 or 750 mg/g for 14 d had no effect on the development rats (Table 4 and Fig. 3) . Average lobulo-alveolar developof the uterus as indicated by uterine weight, relative to the ment in the 17,b-estradiol-treated rats did not differ from control, intact rats (Table 3) .
controls. Average ductal development did not differ for the Induction of uterine c-fos. Uterine tissue from ovariectogenistein-or estradiol-treated groups compared with the conmized rats administered 750 mg/g dietary genistein or 1.0 mg/ trols. Lobulo-alveolar development was significantly greater g 17,b-estradiol and untreated controls were analyzed for the presence of c-fos mRNA (Fig. 2) . Gels were stained with for the groups receiving 750 mg/g genistein or genistein 750 ethidium bromide to confirm equal loading of RNA and to mg/g / 17,b-estradiol 1.0 mg/g, compared with the control assess the integrity of the RNA (data not shown). Both dietary group. The potential of genistein to antagonize the mammatrogenistein and estradiol induced the expression of c-fos mRNA phic effect of estradiol was also evaluated. Coadministration relative to that of the untreated control rats.
of dietary genistein at 150, 375 or 750 mg/g, with 1.0 mg/g Mammatrophic effect of dietary genistein. In Experiment 17,b-estradiol, did not result in lower mammary scores com-2, the mammatrophic effects of dietary genistein were evalupared with rats receiving 17,b-estradiol alone (Table 4) . ated in ovariectomized rats by analyzing the following two In Experiment 3, the effect of genistein on the mammary gland in immature rats was evaluated. Ten rats were killed at the beginning of the study to obtain base-line data for mam -TABLE 3 mary gland development. Dietary genistein had no effect on the development of the mammary gland, as assessed by lobulo- { 0.01 mmol/L and the free concentration of genistein was ANOVA was performed on log-transformed data followed by multiple 0.4 { 0.03 mmol/L. Efficiency of recovery was determined by means comparison using the least significant difference method.
quantifying recovery of a genistein spike from control serum.
2 Baseline rats were killed at the start of dietary treatment. 3 Control rats were not treated.
Average recoveries were 74 { 1.68%.
/ 4w13$$0021 01-17-97 12:27:53 nutra LP: J Nut The experimental groups included an ovariectomized control, base-line, genistein (Gen) 750 mg/g, estradiol (E 2 ) 1 mg/g, E 2 1 mg/g / 150 mg/ g Gen, E 2 1 mg/g / 375 mg/g Gen, and E 2 1 mg/g / 750 mg/g Gen. Values in a column with different superscripts are significantly different (P õ 0.05). Data were ranked and analyzed with Kruskal-Wallis nonparametric ANOVA. Raw mean and rank mean scores are included in the table. When a significant treatment effect was found, the rank means were compared with the least significant difference method.
2 Lob/Av Å lobular/aveolar. 3 Baseline rats were killed at the start of dietary treatment. 4 Control rats were ovariectomized, nontreated.
DISCUSSION
In our study, the coadministration of 150, 375 or 750 mg/g genistein with 1.0 mg/g 17,b-estradiol did not inhibit the efCompetitive binding analysis and induction of c-fos. Comfects of estradiol on uterine weight. In addition, dietary genpetitive binding analysis demonstrated that the relative bindistein did not affect the development of the uterus, when ing affinity of genistein for the rat uterine estrogen receptor administered to immature rats, as assessed by uterine weight (ER) was Ç0.01 that of estradiol. The binding of a compound during maturation of the organ. In the studies reported here, to a receptor does not necessarily result in the production of genistein was administered in the diet to rats, whereas in the a complex capable of initiating the biological response; therestudy by Folman and Pope (1966) , genistein was administered fore, additional studies were undertaken to ascertain whether subcutaneously to mice. The dose of genistein administered in dietary administration of genistein would induce the expresour studies, relative to the dose of estradiol, was much lower sion of an estrogen-responsive gene, c-fos (Weisz and Rosales than that of Folman and Pope. Furthermore, variability in 1990) , in an estrogen-responsive tissue. Uterine expression of species as well as strain in response to compounds with estroc-fos was induced in ovariectomized rats following the dietary genic activity is well documented (reviewed by Adams 1989, administration of genistein or 17,b-estradiol. The variable ex- Farmakalidis and Murphy 1984) . The amount of genistein abpression of c-fos may be due to several factors, including the sorbed from the gut is currently unknown. All of these varifollowing: 1) the timing of food consumption, 2) variability ables could account for the different results obtained in this in food consumption, 3) metabolism of genistein, and 4) the study compared with that of Folman and Pope. short half-life of c-fos mRNA (Greenburg and Ziff 1984) . The Effects of dietary genistein on the mammary gland and induction of c-fos by genistein suggests that genistein is acting plasma prolactin. Dietary genistein consistently elicits an esthrough the ER, similar to estradiol, and is capable of forming trogenic response in the uterus of ovariectomized and immaan active complex with the ER in uterine tissue. ture rodents; however, the effect of dietary genistein on the Uterotrophic effects of dietary genistein. Phytoestrogens mammary gland, another estrogen-responsive tissue, has not have long been recognized for their uterotrophic activity in a been assessed. Increased differentiation of the mammary gland variety of animal species. These effects range from temporary has been observed in prepubertal rats following the subcutaneto permanent infertility (reviewed by Adams 1989). In the ous injection of 5 mg genistein per rat on d 2, 4 and 6 postparpresent study, there was a dose-dependent increase in uterine tum (Lamartiniere et al. 1995) . The model employed in these weight with effects seen at a dietary dose of genistein as low studies utilized 60-d-old rats and assessed the ability of dietary as 375 mg/g diet, suggesting that genistein acts in the uterus genistein and/or estradiol to inhibit mammary gland regression in a manner similar to that of estradiol. That is, genistein postovariectomy. binds to the ER, and the ligand:receptor complex induces the Development and maintenance of the mammary gland in expression of estrogen-responsive genes which ultimately result rats are controlled by many factors including estrogen, progesin increased uterine mass.
terone, growth hormone and prolactin (reviewed by Topper Genistein competes with estradiol binding to the ER and and Freeman 1980) . Estrogen acts directly at the mammary has shown estrogenic effects in estrogen-responsive tissues.
gland by inducing gene transcription and the subsequent transMany antiestrogens, including tamoxifen, possess agonistic lation of many proteins, including the progesterone receptor properties when administered in low amounts; however, in required for progesterone action. Estrogen also acts indirectly higher concentrations, they are antagonists (Martinez-Campos through the induced synthesis and release of prolactin from et al. 1986). As a weak agonist, genistein also has the potential the anterior pituitary gland which then exerts its mitogenic to antagonize the effects of estradiol. Effects of antagonistic effects on the mammary gland. Removal of endogenous estroproperties have been reported in mice coadministered subcutagen results in regression of the mammary gland, particularly neous injections of genistein and estrone. Folman and Pope the lobulo-alveolar structures. Mammary gland regression at (1966) inhibited the uterotrophic effect induced by subcutane-35 d postovariectomy in untreated control rats was greater ous injections in mice of 0.4 mg estrone (total dose) by adminthan that in the untreated base-line rats measured at 14 d istering concurrent subcutaneous injections of either 800 or 1600 mg genistein (total dose) twice daily over a 3-d period.
postovariectomy (the start of dietary treatment). Dietary gen-/ 4w13$$0021 01-17-97 12:27:53 nutra LP: J Nut mammary gland. The reason dietary estradiol exerts estrogenic effects in the uterus and not in the mammary gland is unclear. The ability of genistein to inhibit the effects of estradiol in the mammary gland could not be determined with the dose of estradiol used in this study. It is unlikely that genistein alone is directly responsible for the effects observed in the mammary gland. Maintenance of the mammary gland in rats is also dependent on prolactin. Prolactin synthesis in the anterior pituitary gland is under tonic inhibition by dopamine produced in the hypothalamus (Jones and Naftolin 1990) . Estrogen is thought to decrease the activity of tyrosine hydroxylase, thereby decreasing the concentration of dopamine in the hypothalamus and pituitary (Jones and Naftolin 1990) , resulting in increased plasma prolactin. Genistein or estradiol administered in the diet resulted in increased plasma prolactin compared with the ovariectomized control animals. The increase in plasma prolactin in this study suggests that dietary genistein functions in the hypothalamus and pituitary gland in a manner analogous to that of estradiol, leading to the synthesis and release of prolactin from the anterior pituitary gland.
Estradiol increased uterine weight and plasma prolactin yet did not affect regression of the mammary gland. This suggests that dietary estradiol (1.0 mg/g) is estrogenic in the uterus and on the hypothalamic/pituitary axis. However, this dose was not sufficient to affect the mammary gland.
Serum genistein analysis. Our results indicate that dietary genistein can elicit uterotrophic effects at a dose as low as 375 mg/g, mammatrophic effects at 750 mg/g and effects upon the hypothalamic/pituitary axis at 750 mg/g. The plasma concentration of genistein in rats fed 750 mg/g genistein was 2.2 mmol/ L (conjugated plus free). This concentration was sufficient to elicit estrogenic effects in ovariectomized rodents. The intestinal metabolism, absorption, and half-life of dietary genistein, all of which could affect its bioactivity, are currently unknown. Genistein is present in soy products at concentrations as high as 1500 mg/g (Eldridge 1982) . Women who consumed soy milk powder daily, which contained 227 mg genistein, had plasma genistein concentrations (conjugated plus free) of up to 6.0 mmol/L (Xu et al. 1995) .
At present, there are no human studies in which the biological effects of pure genistein have been assessed and only a few which have evaluated the effects of a diet supplemented with soy. Published studies in which postmenopausal women consumed diets supplemented with soy have yielded conflicting results. Wilcox et al. (1990) showed that soy supplementation produced changes in the uterus similar to those produced by estrogen. However, other studies have failed to show effects different from controls by supplementing soy in the diet of postmenopausal women (Baird et al. 1995) .
FIGURE 3 Photographs of the mammary glands from rats treated
In the studies described here, genistein did not inhibit the with dietary genistein and estradiol. Mammary glands were dissected effects of estrogen in either intact or estrogen-fed ovariectofrom the rats and stained with alum-carmine. Photographs were taken mized rats. However, in ovariectomized rats, genistein stimu- This raises some concern with regard to mammary tumorigenesis, which initially requires estrogen, because these studies have demonstrated that dietary genistein has estrogenic effects in istein prevented regression of the mammary gland compared the mammary gland of ovariectomized rodents. Further rewith the untreated controls. Our goal in this set of experiments search is required in this area to clarify the effects of dietary was to evaluate whether the concurrent administration of gensoy, particularly in postmenopausal women in whom circulatistein at different doses would inhibit the effects of estradiol ing estradiol is low. in preventing regression of the mammary gland. Orally adminGenistein is receiving much attention as a potential chemoistered estradiol (1 mg/g) was effective in increasing uterine weight and plasma prolactin; however, it was ineffective in the preventive/therapeutic agent in the treatment and or preven-/ 4w13$$0021 01-17-97 12:27:53 nutra LP: J Nut
